What is Cobionix?
Cobionix is at the forefront of developing autonomous robotics for the healthcare sector. Its primary innovation, CODI®, is engineered to execute a range of medical procedures, thereby expanding the reach of quality healthcare services and empowering medical professionals to optimize their operations. This strategic capital infusion is expected to accelerate the development and deployment of its groundbreaking technology.
How much funding has Cobionix raised?
Cobionix has raised a total of $3M across 1 funding round:
Other Financing Round
$3M
Other Financing Round (2025): $3M with participation from TitletownTech and Lion Investment Partners
Key Investors in Cobionix
TitletownTech
TitletownTech is a venture capital firm focused on early-stage startups in emerging technology and digital health, aiming to fuel innovation with capital and expertise.
Lion Investment Partners
Lion Investment Partners is a private equity firm specializing in backing mature B2B SaaS technology companies, with a focus on accelerating growth through strategic involvement.
What's next for Cobionix?
With its recent major strategic investment, Cobionix is poised for significant expansion. The company's focus on autonomous healthcare solutions aligns with the growing global demand for accessible and efficient medical services. Future developments are likely to center on enhancing CODI®'s capabilities, expanding its procedural applications, and forging strategic partnerships within the healthcare ecosystem to drive widespread adoption and impact.
See full Cobionix company page
